Vivos (RDGL) EBIT Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.99% |
| Sep 30, 2025 | -32.83% |
| Jun 30, 2025 | -39.34% |
| Mar 31, 2025 | -48.30% |
| Dec 31, 2024 | -15.32% |
| Sep 30, 2024 | -6.79% |
| Jun 30, 2024 | -24.73% |
| Mar 31, 2024 | -20.71% |
| Dec 31, 2023 | 11.37% |
| Sep 30, 2023 | -38.10% |
| Jun 30, 2023 | -21.74% |
| Mar 31, 2023 | 2.83% |
| Dec 31, 2022 | -1.01% |
| Sep 30, 2022 | 22.04% |
| Jun 30, 2022 | -4.93% |
| Mar 31, 2022 | -15.43% |
| Dec 31, 2021 | -29.65% |
| Sep 30, 2021 | 21.82% |
| Jun 30, 2021 | 10.45% |
| Mar 31, 2021 | 19.20% |
| Dec 31, 2020 | 22.95% |
| Sep 30, 2020 | 15.25% |
| Jun 30, 2020 | 17.25% |
| Mar 31, 2020 | 18.21% |
| Dec 31, 2019 | 3.30% |
| Sep 30, 2019 | -4.24% |
| Jun 30, 2019 | 20.12% |
| Mar 31, 2019 | 16.22% |
| Dec 31, 2018 | -33.17% |
| Sep 30, 2018 | 22.49% |
| Jun 30, 2018 | 21.99% |
| Mar 31, 2018 | 28.13% |
| Dec 31, 2017 | 15.15% |
| Sep 30, 2017 | 15.85% |
| Jun 30, 2017 | 22.95% |
| Mar 31, 2017 | 18.41% |
| Dec 31, 2016 | 16.82% |
| Sep 30, 2016 | -4.90% |
| Jun 30, 2016 | -41.29% |
| Mar 31, 2016 | 0.99% |
| Dec 31, 2015 | 3.39% |
| Sep 30, 2015 | 21.11% |
| Jun 30, 2015 | 5.10% |